Stock RELMADA THERAPEUTICS INC
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Calendar Relmada Therapeutics Inc OTC Bulletin Board

Equities

End-of-day quote OTC Bulletin Board
Other stock markets
- USD - Intraday chart for Relmada Therapeutics Inc
12/06 Transcript : Relmada Therapeutics, Inc. Presents at Goldman Sachs 45th Annual Global Healthcare Conference, Jun-12-2024 11:20 AM
05/06 Goldman Sachs Downgrades Relmada Therapeutics to Sell From Neutral With $2 Price Target MT

Chart calendar Relmada Therapeutics Inc

3938e1572a62f1dcf64dc.VPl607mV1-SgfXkdt3odtGHQgN31uA7-kCmeOcN9eag.OqBOufPkltPtKjFn2hZH7C6h6uzClSOy_VHaQaBJQeIcuhSk3cX6kPNNDg~9ef6a064d69607a723c27f146cffe208

Upcoming events on Relmada Therapeutics Inc

06/08/2024 Q2 2024 Earnings Release (Projected)
07/11/2024 Q3 2024 Earnings Release (Projected)
25/03/2025 Q4 2024 Earnings Release (Projected)
07/05/2025 Q1 2025 Earnings Release (Projected)

Past events on Relmada Therapeutics Inc

12/06/2024 08:50 pm Goldman Sachs Global Healthcare Conference
06/06/2024 05:00 pm Jefferies Global Healthcare Conference
24/05/2024 07:00 pm Annual General Meeting
09/05/2024 02:00 am Q1 2024 Earnings Call
09/05/2024 01:35 am Q1 2024 Earnings Release
20/03/2024 02:00 am Q4 2023 Earnings Call
20/03/2024 01:45 am Q4 2023 Earnings Release
11/03/2024 Leerink Partners Global Biopharma Conference
11/11/2023 06:30 pm AASLD Liver Meeting - Abstract Number: 2468-C
09/11/2023 03:00 am Q3 2023 Earnings Call
09/11/2023 02:31 am Q3 2023 Earnings Release
13/10/2023 12:00 am Jefferies Inaugural Biotech CNS/Neuro Summit
08/10/2023 04:05 pm European College of Neuropsychopharmacology Congress - Poster No: P.0399
08/10/2023 04:05 pm European College of Neuropsychopharmacology Congress - Poster No: P.0166
08/10/2023 04:05 pm European College of Neuropsychopharmacology Congress - Poster No: P.0165
09/08/2023 02:00 am Q2 2023 Earnings Call
09/08/2023 01:31 am Q2 2023 Earnings Release
15/06/2023 03:50 am Goldman Sachs Global Healthcare Conference
09/06/2023 12:30 am Jefferies Global Healthcare Conference
01/06/2023 10:00 pm American Society of Clinical Psychopharmacology Meeting - Poster No T46

Annual results

Fiscal PeriodDecember 2020 2021 2022 2023 2024
Net sales
Million USD		Released
Forecast
Spread 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
-
0,00

EBITDA
Million USD		Released
Forecast
Spread 		-60,8
-64,2
5.26%		-85,2
-98,7
13.67%		-161
-152
-6.08%		0,00
0,00
-
0,00

EBIT
Million USD		Released
Forecast
Spread 		-60,8
-59,2
-2.77%		-126
-127
0.87%		-161
-162
0.48%		-104
-103
-0.74%
-105

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		-59,5
-56,6
-5.08%		-126
-127
0.6%		-157
-158
0.82%		-98,8
-98,9
0.1%
-102

Net income
Million USD		Released
Forecast
Spread 		-59,5
-56,6
-5.08%		-126
-126
0.56%		-157
-159
0.99%		-98,8
-99,3
0.51%
-102

EPS
USD		Released
Forecast
Spread 		-3,81
-3,56
-7.08%		-7,16
-7,16
-0.02%		-5,30
-5,37
1.3%		-3,28
-3,28
-0.12%
-3,01

Announcement Date23/03/2123/03/2223/03/2319/03/24-

Quarterly results

Fiscal PeriodDecember 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales
Million USD		Released
Forecast
Spread 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
-
0,00


0,00


0,00


0,00


0,00

EBIT
Million USD		Released
Forecast
Spread 		-38,3
-34,1
-12.31%		-45,5
-38,3
-18.94%		-38,7
-44,1
12.08%		-38,7
-39,4
1.67%		-28,2
-34,4
18.16%		-26,0
-28,3
7.99%		-22,7
-28,3
19.72%		-26,8
-25,4
-5.77%		-23,0
-26,4
12.81%
-26,1


-27,7


-30,2


-34,7


-38,0

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		-39,7
-33,6
-18.38%		-39,9
-37,7
-5.82%		-39,4
-42,1
6.48%		-37,9
-38,7
1.99%		-26,3
-36,6
27.98%		-25,3
-26,3
3.66%		-22,0
-27,0
18.36%		-25,2
-24,2
-4.2%		-21,8
-24,7
11.45%
-23,8


-26,0


-29,6


-33,1


-36,4

Net income
Million USD		Released
Forecast
Spread 		-39,7
-33,8
-17.52%		-39,9
-37,7
-5.84%		-39,4
-43,0
8.41%		-37,9
-39,3
3.36%		-26,3
-28,3
6.83%		-25,3
-26,6
5.05%		-22,0
-28,1
21.7%		-25,2
-25,2
0.14%		-21,8
-25,6
14.84%
-24,8


-26,0


-29,0


-33,1


-36,4

EPS
USD		Released
Forecast
Spread 		-1,40
-1,27
-10.61%		-1,33
-1,27
-4.49%		-1,31
-1,46
10.48%		-1,26
-1,33
5.41%		-0,87
-0,89
2.25%		-0,84
-0,90
6.32%		-0,73
-0,91
20.13%		-0,84
-0,83
-1.2%		-0,72
-0,86
16.28%
-0,83


-0,78


-0,72


-0,94


-1,03

Announcement Date05/05/2211/08/2210/11/2223/03/2311/05/2308/08/2308/11/2319/03/2408/05/24-----

Upcoming sector events for Relmada Therapeutics Inc

24/07/2024 VIKING THERAPEUTICS, INC.: Q2 2024 Earnings Release (Projected)
25/07/2024 BIOCON LIMITED: Q1 2025 Earnings Release (Projected)
25/07/2024 10:30 am ARGENX SE: Q2 2024 Earnings Release
30/07/2024 RHYTHM PHARMACEUTICALS, INC.: Q2 2024 Earnings Release (Projected)
30/07/2024 NEUROCRINE BIOSCIENCES, INC.: Q2 2024 Earnings Release (Projected)
30/07/2024 CEREVEL THERAPEUTICS HOLDINGS, INC.: Q2 2024 Earnings Release (Projected)
31/07/2024 CASSAVA SCIENCES, INC.: Q2 2024 Earnings Release (Projected)
31/07/2024 SPRINGWORKS THERAPEUTICS, INC.: Q2 2024 Earnings Release (Projected)
31/07/2024 XENCOR, INC.: Q2 2024 Earnings Release (Projected)
31/07/2024 SAREPTA THERAPEUTICS, INC.: Q2 2024 Earnings Release (Projected)
More events

Past sector events for Relmada Therapeutics Inc

05/06/2024 01:21 pm PHARMAESSENTIA CORPORATION: May 2024 Sales and Revenue Release
17/05/2024 04:30 pm AUTOLUS THERAPEUTICS PLC: Q1 2024 Earnings Release
16/05/2024 05:16 pm BIOCON LIMITED: Q4 2024 Earnings Release
16/05/2024 10:30 am ZEALAND PHARMA A/S: Q1 2024 Earnings Release
16/05/2024 LIGACHEM BIOSCIENCES INC.: Q1 2024 Earnings Release
15/05/2024 05:35 pm THIRD HARMONIC BIO, INC.: Q1 2024 Earnings Release
15/05/2024 04:30 pm CABALETTA BIO, INC.: Q1 2024 Earnings Release
15/05/2024 TAIMED BIOLOGICS INC.: Q1 2024 Earnings Release
15/05/2024 01:35 am ENLIVEN THERAPEUTICS, INC.: Q1 2024 Earnings Release
15/05/2024 01:30 am ARCUTIS BIOTHERAPEUTICS, INC.: Q1 2024 Earnings Release
  1. Stock Market
  2. Equities
  3. RLMD Stock
  4. Stock
  5. Calendar Relmada Therapeutics Inc